12 results match your criteria: "Cytecare Cancer Hospital[Affiliation]"

Actinomycosis is an uncommon infection of the middle ear.Actinomycosis of ear can mimic other common diagnosis of middle ear. The treatment of actinomycosis of the middle ear differs from that of otitis media caused by aerobic bacteria, therefore an accurate diagnosis is necessary.

View Article and Find Full Text PDF

Objective: The 2x2 factorial design is an effective method that allows for multiple comparisons, especially in the context of interactions between different interventions, without substantially increasing the required sample size. In view of the considerable preclinical evidence for Curcumin and Metformin in preventing the development and progression of head and neck squamous cell carcinoma (HNSCC), this study describes the protocol of the clinical trial towards applying the drug combination in prevention of second primary tumors.

Methods: We have applied the trial design to a large phase IIB/III double-blind, multi-centric, placebo-controlled, randomized clinical trial to determine the safety and efficacy of Metformin and Curcumin in the prevention of second primary tumours (SPT) of the aerodigestive tract following treatment of HNSCC (n=1,500) [Clinical Registry of India, CTRI/2018/03/012274].

View Article and Find Full Text PDF

Objectives: Trans-nasal humidified rapid insufflation ventilatory exchange (THRIVE) has demonstrated utility in extending the apneic window in the perioperative setting. Its benefits in facilitating tubeless anesthesia are recognized during elective laryngotracheal surgeries. The use of THRIVE and administering higher fractional inspired oxygen concentrations in laser laryngeal surgery (LLS) remains controversial due to the theoretical risk of airway fires.

View Article and Find Full Text PDF
Article Synopsis
  • - High-flow nasal oxygen (HFNO) therapy, specifically THRIVE, provides continuous delivery of warm, humidified oxygen at high flow rates (up to 70L/min), extending the time patients can remain apnoeic without desaturation.
  • - THRIVE has significantly influenced anaesthetic practices, being included in difficult airway guidelines and utilized for various surgical applications, especially in otolaryngology and head and neck surgeries.
  • - This scoping review examines THRIVE's effectiveness in otolaryngology, covering its physiological principles, current uses and risks, and its safety across different surgical settings and patient populations.
View Article and Find Full Text PDF

A Retrospective Cohort Study to Evaluate the Outcomes of HIV-Associated High-Grade B-Cell Non-Hodgkin Lymphoma (NHL) Treated with Dose Adjusted EPOCH (+/-R) Regimen.

Indian J Hematol Blood Transfus

January 2024

Department of Medical Oncology, Tata Memorial Centre, Tata Memorial Hospital, Homi Bhabha National Institute, Room-21, Main Building, E. Borges Road, Parel, Mumbai, 400012 India.

Article Synopsis
  • High-grade B-cell non-Hodgkin lymphomas (NHLs) are more prevalent in patients with HIV, and this study reflects on the treatment outcomes of such patients treated with a specific chemotherapy regimen called DA-EPOCH(+/-R) from 2011 to 2015.
  • The analysis included 40 patients with various types of B-cell NHL, and a notable 82.5% had a 5-year overall survival rate, indicating the regimen's effectiveness.
  • While most patients experienced significant side effects, such as febrile neutropenia and mucositis, the treatment remains a viable option even for those with serious health challenges related to HIV.
View Article and Find Full Text PDF

Background And Aims: In emergency and non-fasting patients posted for laparotomy under general anaesthesia, rapid sequence induction (RSI) is preferred, and it is routinely done by using succinylcholine or rocuronium. Using higher doses of atracurium [i.e.

View Article and Find Full Text PDF

Cystic hydatid disease or cystic echinococcosis (CE) is a globally endemic zoonosis caused by the larval cyst stage of the tapeworm Concomitant presence of CE and hepatocellular carcinoma (HCC) is a rare clinical scenario. A 70-year-old male patient presented with acute abdominal pain to the surgical outpatient department. On evaluation, a cystic lesion with solid components and free fluid in the abdomen was observed, which led to multiple differentials in the working diagnosis.

View Article and Find Full Text PDF

We accrued 201 patients of adult AML treated with conventional therapy, in morphological remission, and evaluated MRD using sensitive error-corrected next generation sequencing (NGS-MRD) and multiparameter flow cytometry (FCM-MRD) at the end of induction (PI) and consolidation (PC). Nearly 71% of patients were PI NGS-MRD and 40.9% PC NGS-MRD (median VAF 0.

View Article and Find Full Text PDF

One of the mainstays of chemotherapy in acute myeloid leukemia (AML) is induction with a goal to achieve morphological complete remission (CR). However, not all patients by this remission criterion achieve long-term remission and a subset relapse. This relapse is explained by the presence of measurable residual disease (MRD).

View Article and Find Full Text PDF
Article Synopsis
  • The correction addresses errors found in the original article referenced by DOI: 10.18632/oncotarget.26400.
  • It clarifies specific details that were inaccurately presented, ensuring the information is accurate.
  • This update is important for maintaining the integrity of the research findings in the field.
View Article and Find Full Text PDF

Detection of measurable residual disease (MRD) by mutation specific techniques has prognostic relevance in mutated AML ( AML). However, the clinical utility of next generation sequencing (NGS) to detect MRD in AML remains unproven. We analysed the clinical significance of monitoring MRD using ultradeep NGS (NGS-MRD) and flow cytometry (FCM-MRD) in 137 samples obtained from 83 patients of AML at the end of induction (PI) and consolidation (PC).

View Article and Find Full Text PDF

Human papillomavirus (HPV) associated head and neck squamous cell cancers (HNSCC) have become increasingly common in the West, but the same cannot be said about India. These cancers have a different biology and confer a better prognosis, however, its current role in the management of patients in India is not clearly defined. At the 35 Indian Cooperative Oncology Network conference held in September 2016, a panel of radiation, surgical and medical oncologists, pathologists, and basic scientists from across the country having experience in clinical research with respect to HPV in HNSCC reviewed the available literature from India.

View Article and Find Full Text PDF